Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value
$266.71M
Total Bought
$51.40M
Total Sold
$39.59M
Net Transaction
+$11.81M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
KEROS THERAPEUTICS INC(KROS)0544,001+544,00108,6123.23%+8,612
CULLINAN THERAPEUTICS INC(CGEM)410,8301,257,795+846,9656,87715,3205.74%+8,443
GH RESEARCH PLC(GHRS)4,195,8944,858,994+663,10028,07134,01312.75%+5,942
ALLOGENE THERAPEUTICS INC6,202,37410,874,723+4,672,34917,36723,1638.68%+5,797
ALLAKOS INC03,628,144+3,628,14404,3901.65%+4,390
UPSTREAM BIO INC(UPB)0240,042+240,04203,9461.48%+3,946
PRECISION BIOSCIENCES INC(DTIL)0766,051+766,05102,9191.09%+2,919
VOR BIOPHARMA INC(VOR)0637,218+637,21807070.27%+707
IBIO INC(IBIO)862,279862,27901,9142,1130.79%+198
NEUPHORIA THERAPEUTICS INC045,806+45,80601570.06%+157
REPARE THERAPEUTICS INC079,176+79,17601040.04%+104
CENTESSA PHARMACEUTICALS PLC17,40017,40002782910.11%+13
VYNE THERAPEUTICS INC(YARW)16,1940-16,194300—-30
CENTURY THERAPEUTICS INC(IPSC)19,0280-19,028330—-33
TENAX THERAPEUTICS INC(TENX)14,7510-14,751510—-51
KINIKSA PHARMACEUTICALS INTL(KNSA)8,2310-8,2312060—-206
BIONOMICS LIMITED549,6730-549,6732410—-241
CARIBOU BIOSCIENCES INC(CRBU)680,189680,18901,3331,0820.41%-252
PIERIS PHARMACEUTICALS INC37,4360-37,4366210—-621
PASSAGE BIO INC(PASG)8,426,9559,256,953+829,9985,8995,2501.97%-649
KODIAK SCIENCES INC(KOD)271,1770-271,1777080—-708
STOKE THERAPEUTICS INC(STOK)5,187,1915,187,191063,75157,21521.45%-6,536
TSCAN THERAPEUTICS INC(TCRX)5,224,6005,357,347+132,74726,01916,2866.11%-9,732
C4 THERAPEUTICS INC(CCCC)6,880,5276,852,744-27,78339,21924,6709.25%-14,549
MERUS N V1,793,8661,580,841-213,02589,62266,47424.92%-23,147
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q4 2024 | TickerTrail